US Patent Issued to SCL HEALTHCARE on Aug. 4 for "Composition for diagnosis or prediction of metabolic syndrome or group at high risk of expression of blood ceramide" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,533, issued on Aug. 4, was assigned to SCL HEALTHCARE Co. LTD. (Yongin-si, South Korea).

"Composition for diagnosis or prediction of metabolic syndrome or group at high risk of expression of blood ceramide" was invented by Sang Hoo Lee (Yongin-si, South Korea), Ye Jin Kim (Yongin-si, South Korea), Ju Hoon Kim (Yongin-si, South Korea), Jeong Hoon Hong (Yongin-si, South Korea), Yi Seul Kim (Yongin-si, South Korea), Sae Yun Baik (Yongin-si, South Korea) and Kyoung Ryul Lee (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for diagnosing or predicting a metabolic syndrome and a compositi...